{
    "2021-05-11": [
        [
            {
                "time": "2021-05-12",
                "original_text": "云南白药(000538.SZ)拟战略入股上海医药持股达18.02%",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "战略入股",
                        "持股18.02%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "上海医药(02607.HK)建议向上海潭东及云南白药发A股筹143.83亿人民币",
                "features": {
                    "keywords": [
                        "上海医药",
                        "云南白药",
                        "定增",
                        "募资143.83亿"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "云南白药：拟参与认购上海医药定增",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "定增认购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "向前看，入股上海医药对于云南白药的医药商业板块全国性扩张及国际化发展意义是非常重大的。",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "全国性扩张",
                        "国际化发展"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "上海医药(601607.SH)拟定增募资不超143.84亿元由上海潭东及云南白药认购",
                "features": {
                    "keywords": [
                        "上海医药",
                        "云南白药",
                        "定增募资",
                        "143.84亿"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "上海医药：拟定增募资不超143.84亿元，云南白药认购112亿元",
                "features": {
                    "keywords": [
                        "上海医药",
                        "云南白药",
                        "定增募资",
                        "112亿认购"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}